Sitrin Capital Management’s AbbVie ABBV Stock Holding History

Sitrin Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$5.95M	Sell	27,377 -446	-2%	-$98.9K	2.98%	17
2025 Q4	$6.36M	Buy	27,823 +456	+2%	+$104K	3.02%	17
2025 Q3	$6.34M	Buy	27,367 +23,435	+596%	+$4.77M	3.04%	16
2025 Q2	$730K	Hold	3,932	–	–	0.37%	33
2025 Q1	$824K	Hold	3,932	–	–	0.44%	33
2024 Q4	$699K	Sell	3,932 -10	-0.3%	-$1.84K	0.35%	34
2024 Q3	$778K	Buy	+3,942	New	+$736K	0.39%	34
2020 Q2	–	Sell	-3,932	Closed	-$300K	–	33
2020 Q1	$300K	Hold	3,932	–	–	0.18%	33
2019 Q4	$348K	Hold	3,932	–	–	0.18%	33
2019 Q3	$298K	Hold	3,932	–	–	0.16%	35
2019 Q2	$286K	Hold	3,932	–	–	0.15%	34
2019 Q1	$317K	Hold	3,932	–	–	0.17%	35
2018 Q4	$362K	Hold	3,932	–	–	0.22%	33
2018 Q3	$372K	Hold	3,932	–	–	0.2%	33
2018 Q2	$364K	Hold	3,932	–	–	0.21%	35
2018 Q1	$372K	Hold	3,932	–	–	0.24%	35
2017 Q4	$380K	Hold	3,932	–	–	0.24%	35
2017 Q3	$349K	Hold	3,932	–	–	0.22%	35
2017 Q2	$285K	Hold	3,932	–	–	0.19%	34
2017 Q1	$256K	Hold	3,932	–	–	0.18%	35
2016 Q4	$246K	Hold	3,932	–	–	0.19%	35
2016 Q3	$248K	Hold	3,932	–	–	0.19%	35
2016 Q2	$243K	Hold	3,932	–	–	0.2%	34
2016 Q1	$225K	Hold	3,932	–	–	0.18%	35
2015 Q4	$219K	Buy	+3,932	New	+$226K	0.19%	35

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Sitrin Capital Management's ABBV Position: Q1 2026 in Review

Sitrin Capital Management reduced its AbbVie (ABBV) stake by 1.6% in Q1 2026, selling an estimated $98.9K and leaving 27,377 shares worth $5.95M. The position accounts for 2.98% of the portfolio, ranked #17.

Sitrin Capital Management first reported a position in ABBV in Q4 2015 and has held it in 25 quarters since. The position peaked at $6.36M in Q4 2025. 4,080 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

Sitrin Capital Management held 27,377 shares of AbbVie worth $5.95M as of Q1 2026.
Sitrin Capital Management sold 446 AbbVie shares in Q1 2026, an estimated $98.9K.
AbbVie made up 2.98% of Sitrin Capital Management's portfolio in Q1 2026, its #17 holding.
Sitrin Capital Management first reported a position in AbbVie in Q4 2015 and has held it in 25 quarters since.
Sitrin Capital Management's AbbVie position peaked at $6.36M in Q4 2025.
4,080 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Sitrin Capital Management's 13F filing for Q1 2026, filed 22 Apr 2026.